Biosenta Inc.
ZRO
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -30.90% | -8.93% | -6.04% | 91.11% | -958.60% |
| Total Depreciation and Amortization | 0.00% | -58.33% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 197.79% | -39.72% | 140.71% | -97.38% | 3,320.59% |
| Change in Net Operating Assets | -33.81% | 1,743.08% | 324.14% | -101.25% | 64.59% |
| Cash from Operations | 72.62% | -7.23% | 47.50% | -175.43% | 24.06% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -200.97% | 10,180.00% | -99.57% | -36.29% |
| Total Debt Repaid | 115.56% | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 180,050.00% | -200.00% | 101.43% | -- | -- |
| Cash from Financing | -70.07% | 258.49% | -89.29% | 308.22% | -36.24% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 124.24% | 93.12% | -194.02% | 710.78% | -209.15% |
